Fennec Pharmaceuticals (FENC) Return on Sales (2020 - 2025)

Fennec Pharmaceuticals' Return on Sales history runs 5 years deep, the most recent figure standing at 0.0% for Q4 2025.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales was 0.0% for Q4 2025 at Fennec Pharmaceuticals, down from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.01% in Q1 2024 and bottomed at 2.5% in Q1 2021.
• A 4-year average of 0.2% and a median of 0.0% in 2025 frame the typical range for Return on Sales.
• Peak annual rise in Return on Sales reached 4 bps in 2024, while the deepest fall reached 1 bps in 2024.
• Fennec Pharmaceuticals' Return on Sales stood at 2.5% in 2021, then soared by 100 bps to 0.0% in 2023, then gained by 30 bps to 0.0% in 2024, then slumped by 81 bps to 0.0% in 2025.
• Business Quant data shows FENC's Return on Sales at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.